|
The study focused on a drug referred to as anacetrapib, aiming for a really secure control over cholesterol level. This pharmaceutical is surely part of new medicines known as CETP inhibitors managing bad cholesterol by inducing HDLs rise (good cholesterol). In other words, the anacetrapib has the role to carry fat deposits from arteries to the liver. Afterwards, the body eliminates fat deposits.
|
